Teva Pharmaceutical Industries (TEVA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Trending

Earning Release Date

FY2025 Q4 Earning Release 2026.01.28 (EST) Pre-Market

Event Tracking

Dec24

Teva's Credit Rating Upgraded by S&P, Moody's Outlook Revised to Positive

13:36

Dec22

Teva Pharmaceuticals Reaches New 52-Week High with Raised Target Price

15:44

Teva Pharmaceutical Industries Upgraded by Analysts

12:22

Dec19

Teva's CFO Sells Company Shares

15:15

Alvotech and Teva Reach Settlement with Regeneron for AVT06 US Launch

08:32

Dec18

Teva Pharmaceuticals Director Roberto Minio Sells Common Stocks

21:03

Schedules & Filings

Schedules

Filings

Jan28

Earning Release(EST)

FY2025 Q4 Earning Release

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 4.48 B, Net Income 433 M, EPS 0.37

Jul30

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.176 B, Net Income 282 M, EPS 0.24

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More